You are invited to participate in the following survey about biologics clinical handling. The goal is to improve the understanding of how biologics are handled in the real world and the effect this has on product quality. The results will be used to generate a white paper to help craft the next generation of rules in handling biologics with more transparent information sharing, thus bridging the gulf between drug developers, regulators and their users by careful education.

Participation in this study is voluntary.  The survey should only take 5-10 minutes, and your responses will be kept completely anonymous during analysis.

Continue to the survey →